Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

EHRA Score

EHRA Score (Modified): Stratifies symptom severity in Atrial Fibrillation. Essential for decision-making regarding rhythm control strategies.

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Routinely in the clinical assessment and follow-up of patients with Atrial Fibrillation
To guide the decision between a rate-control vs. rhythm-control (cardioversion, antiarrhythmics, ablation) strategy

How it Works

The 2014 Modification

The original EHRA score had 4 classes. It was modified by the European Heart Rhythm Association to split Class II into IIa and IIb based on whether symptoms "trouble" the patient. This split is clinically vital because it represents the exact threshold where European and American guidelines recommend considering rhythm control therapies.

Subjective Nature

01
Class I: Asymptomatic AF. Pure rate control is usually sufficient unless tachycardia-induced cardiomyopathy develops.
02
Class IIa: Mild symptoms. Typically managed with rate control.
03
Class IIb: Troubling symptoms. Strong indication to consider restoration of sinus rhythm.
04
Class III/IV: Severe/Disabling. Definite indication for rhythm control (ablation or AADs).

Clinical Pearls

Asymptomatic vs Adjusting

Many patients categorized as EHRA I (Asymptomatic) have actually just subconsciously slowly reduced their daily activities to avoid dyspnea. A careful history exploring exactly what they do in a day, compared to a year ago, often reclassifies them to EHRA II or III.

Symptom Fluctuation

EHRA scores can fluctuate based on ventricular rate. Always assess the EHRA score when the patient is in AF, and document whether their rate was controlled at the time of assessment.

The Evidence

Original Consensus Document

Outcome parameters for trials in atrial fibrillation: executive summary.

Kirchhof P et al. • Eur Heart J.. 2007;28(22):2803-17. First proposal of the EHRA classification.

The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.

Wynn GJ et al. • Europace.. 2014;16(7):965-72. Validated the split of Class II into IIa and IIb.

Last Comprehensive Review: 2026-07-17

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Routinely in the clinical assessment and follow-up of patients with Atrial Fibrillation
To guide the decision between a rate-control vs. rhythm-control (cardioversion, antiarrhythmics, ablation) strategy

How it Works

The 2014 Modification

The original EHRA score had 4 classes. It was modified by the European Heart Rhythm Association to split Class II into IIa and IIb based on whether symptoms "trouble" the patient. This split is clinically vital because it represents the exact threshold where European and American guidelines recommend considering rhythm control therapies.

Subjective Nature

01
Class I: Asymptomatic AF. Pure rate control is usually sufficient unless tachycardia-induced cardiomyopathy develops.
02
Class IIa: Mild symptoms. Typically managed with rate control.
03
Class IIb: Troubling symptoms. Strong indication to consider restoration of sinus rhythm.
04
Class III/IV: Severe/Disabling. Definite indication for rhythm control (ablation or AADs).

Clinical Pearls

Asymptomatic vs Adjusting

Many patients categorized as EHRA I (Asymptomatic) have actually just subconsciously slowly reduced their daily activities to avoid dyspnea. A careful history exploring exactly what they do in a day, compared to a year ago, often reclassifies them to EHRA II or III.

Symptom Fluctuation

EHRA scores can fluctuate based on ventricular rate. Always assess the EHRA score when the patient is in AF, and document whether their rate was controlled at the time of assessment.

The Evidence

Original Consensus Document

Outcome parameters for trials in atrial fibrillation: executive summary.

Kirchhof P et al. • Eur Heart J.. 2007;28(22):2803-17. First proposal of the EHRA classification.

The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.

Wynn GJ et al. • Europace.. 2014;16(7):965-72. Validated the split of Class II into IIa and IIb.

Last Comprehensive Review: 2026-07-17

Related Tools

CHA2DS2-VASc
HAS-BLED
ORBIT Score
CHADS2
ABC-AF Stroke Score
eGFR
Cardiovascular CalculatorsCritical Care CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.

Recent Journal Updates

JAMAJul 21, 2026
Errors in Figures

Clinical Context

We think this has broad domain relevance to EHRA Score.

JAMAJul 21, 2026
Correction to Primary Composite Outcome in a Trial of Transfusion Strategy

Clinical Context

We think this has broad domain relevance to EHRA Score.

WHO NewsJul 20, 2026
Road deaths fall by 21% globally but stronger action is needed to save lives

Clinical Context

We think this has broad domain relevance to EHRA Score.